Termination of KCI LUNA agreement is a positive develpment for Novadaq
NVDQ is now free to continue their development and ultimate launch of their wound care diagnostic device and market it independently. This means 2/3 instead of 1/3 of their market potential will be 100% owned. As they will break even soon, perhaps this coming quarter, and cash on hand is ~$40 million, they should be able to handle the rest of development and marketing from their current cash holdings and future earnings from ISRG and Lifecell with help from Pinpoint 1-2 years out when they will need to ramp up marketing, sales and support personel for the new LUNA market. All in all I see this as positive news.
I agree that is probably a long-term positive, but I'm not sure of your timeframe of "1-2 years out" to ramp up marketing for LUNA. In the press release they speak to how terminating the agreement with KCI will allow them to "accelerate the launch" and how the commercialization begins this month at the DFCon conference - based on those comments, I would expect they would have a full marketing launch in place by the end of the year?
It takes time to staff up and train sales and marketing folks. They are currently pushing as hard as they can to hire for PinPoint. The word on the street is they are looking to hire 50 marketing/sales reps.